884 reports of this reaction
1.8% of all MINOCYCLINE HYDROCHLORIDE reports
#5 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #5 most commonly reported adverse reaction for MINOCYCLINE HYDROCHLORIDE, manufactured by Melinta Therapeutics, LLC. There are 884 FDA adverse event reports linking MINOCYCLINE HYDROCHLORIDE to RHEUMATOID ARTHRITIS. This represents approximately 1.8% of all 49,345 adverse event reports for this drug.
Patients taking MINOCYCLINE HYDROCHLORIDE who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is a less commonly reported adverse event for MINOCYCLINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for MINOCYCLINE HYDROCHLORIDE:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 884 FDA reports for MINOCYCLINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 1.8% of all adverse event reports for MINOCYCLINE HYDROCHLORIDE, making it a notable side effect.
If you experience rheumatoid arthritis while taking MINOCYCLINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.